Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CICLOPIROX vs CILGAVIMAB\TIXAGEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CICLOPIROX vs CILGAVIMAB\TIXAGEVIMAB: Safety Overview

Metric CICLOPIROX CILGAVIMAB\TIXAGEVIMAB
Total FAERS Reports 536 2,168
Deaths Reported 0 359
Death Rate N/A 16.6%
Hospitalizations 44 998
Average Patient Age 62.5 yrs 62.2 yrs
% Female Patients 57.6% 47.6%
FDA Approval Date Apr 12, 2005 N/A
Manufacturer Padagis Israel Pharmaceuticals Ltd N/A
Route TOPICAL N/A
Marketing Status Prescription N/A